Your browser doesn't support javascript.
The impact of COVID-19 on mortality after hip fracture : a population cohort study from England.
Holleyman, Richard J; Khan, Sameer K; Charlett, Andre; Inman, Dominic S; Johansen, Antony; Brown, Colin; Barnard, Sharmani; Fox, Sebastian; Baker, Paul N; Deehan, David; Burton, Paul; Gregson, Celia L.
  • Holleyman RJ; Public Health England, London, UK.
  • Khan SK; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Charlett A; Northumbria Healthcare NHS Foundation Trust, Cramlington, UK.
  • Inman DS; Public Health England, London, UK.
  • Johansen A; Northumbria Healthcare NHS Foundation Trust, Cramlington, UK.
  • Brown C; University Hospital of Wales, Cardiff, UK.
  • Barnard S; Public Health England, London, UK.
  • Fox S; Public Health England, London, UK.
  • Baker PN; Public Health England, London, UK.
  • Deehan D; James Cook University Hospital, South Tees NHS Foundation Trust, Middlesbrough, UK.
  • Burton P; York Medical School, University of York, York, UK.
  • Gregson CL; Teeside University, Middlesbrough, UK.
Bone Joint J ; 104-B(10): 1156-1167, 2022 Oct.
Article in English | MEDLINE | ID: covidwho-2196752
ABSTRACT

AIMS:

Hip fracture commonly affects the frailest patients, of whom many are care-dependent, with a disproportionate risk of contracting COVID-19. We examined the impact of COVID-19 infection on hip fracture mortality in England.

METHODS:

We conducted a cohort study of patients with hip fracture recorded in the National Hip Fracture Database between 1 February 2019 and 31 October 2020 in England. Data were linked to Hospital Episode Statistics to quantify patient characteristics and comorbidities, Office for National Statistics mortality data, and Public Health England's SARS-CoV-2 testing results. Multivariable Cox regression examined determinants of 90-day mortality. Excess mortality attributable to COVID-19 was quantified using Quasi-Poisson models.

RESULTS:

Analysis of 102,900 hip fractures (42,630 occurring during the pandemic) revealed that among those with COVID-19 infection at presentation (n = 1,120) there was a doubling of 90-day mortality; hazard ratio (HR) 2.09 (95% confidence interval (CI) 1.89 to 2.31), while the HR for infections arising between eight and 30 days after presentation (n = 1,644) the figure was greater at 2.51 (95% CI 2.31 to 2.73). Malnutrition (1.45 (95% CI 1.19 to 1.77)) and nonoperative treatment (2.94 (95% CI 2.18 to 3.95)) were the only modifiable risk factors for death in COVID-19-positive patients. Patients who had tested positive for COVID-19 more than two weeks prior to hip fracture initially had better survival compared to those who contracted COVID-19 around the time of their hip fracture; however, survival rapidly declined and by 365 days the combination of hip fracture and COVID-19 infection was associated with a 50% mortality rate. Between 1 January and 30 June 2020, 1,273 (99.7% CI 1,077 to 1,465) excess deaths occurred within 90 days of hip fracture, representing an excess mortality of 23% (99.7% CI 20% to 26%), with most deaths occurring within 30 days.

CONCLUSION:

COVID-19 infection more than doubles the rate of early hip fracture mortality. Those contracting infection between 8 and 30 days after initial presentation are at even higher mortality risk, signalling the potential for targeted interventions during this period to improve survival.Cite this article Bone Joint J 2022;104-B(10)1156-1167.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hip Fractures Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Bone Joint J Year: 2022 Document Type: Article Affiliation country: 0301-620X.104B10.BJJ-2022-0082.R1

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hip Fractures Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Bone Joint J Year: 2022 Document Type: Article Affiliation country: 0301-620X.104B10.BJJ-2022-0082.R1